PATENT CLAIM ANALYSIS

Application Number: 15759060
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-01
Patent Classification: ["514", "012700"]

Abstract:
The present invention relates to relaxin or a homologue or variant thereof for use in a method of treating an inflammatory condition, for example an autoimmune inflammatory condition. The invention also relates to the treatment of an inflammatory condition, for example an autoimmune inflammatory condition comprising administering to a subject in need thereof a relaxin, or a homologue or variant thereof. Such conditions may be CNS conditions or be organ specific.

Claim (Index 14):
The method according to  claim 13  wherein the condition is Diffuse cerebral sclerosis of Schilder; Acute disseminated encephalomyelitis; Acute hemorrhagic leukoencephalitis; Transverse myelitis; and Neuromyelitis optica.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 90.0
- Lexical Diversity: 2.02632
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12100196', '14128919', '11119333', '12897591', '15703457']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7650574009615116
- 35 USC 102 Novelty (BERT): 0.5145379675451309
- Combined Prediction Score: 0.7400054576198736
- Mean Citation Score: 234.375084
- Max Citation Score: 252.24265
- Similarity Product: 150.59386937124432

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test